ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards
In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.
Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening
Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says
Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants
In Brief: Ahoy! It’s “Admiral Rick”
Professional Societies: AACR Awards Honor 8 Scientists, Clinicians
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









